RT Journal Article
SR Electronic
T1 Effectiveness and Safety of Type- and Energy-based Extracorporeal Shockwave Therapy in Clinical Practice: Umbrella Review and Evidence Mapping
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.01.07.24300948
DO 10.1101/2024.01.07.24300948
A1 Qingcong Mo
A1 Jialing Zheng
A1 Fangfei Hu
A1 Peng Gao
A1 Tong Wu
A1 Simeng Wei
A1 Jiaqi Zhang
A1 Chun-Zhi Tang
A1 Jihua Zou
A1 Xiaoyan Zheng
YR 2024
UL http://medrxiv.org/content/early/2024/01/09/2024.01.07.24300948.abstract
AB Background The role of distinct type- and energy-based extracorporeal shockwave therapy (ESWT) in clinical practice is unclear.Objectives To appraise meta-analytically determined effectiveness and safety of type- and energy-based ESWT for diseases or conditions, and visualize evidence maps of findings.Methods Nine online databases and reference lists were systematically searched for systematic reviews (SRs) of randomized controlled trials (RCTs) evaluating the effectiveness or safety of ESWT from inception to September 2023. SRs were then updated if up-to-date RCTs were eligible. Overall effects were re-estimated using random-effects model and reported as relative risk or standardized mean difference with 95% confidence intervals. Methodological quality, certainty of evidence, and safety were assessed with AMSTAR 2, GRADE tool, and MedDRA, respectively.Results Our research identified 210 relevant SRs encompassing 636 RCTs and 41649 participants across 7 therapeutic areas and 37 diseases and conditions. Methodological quality of most published SRs was low or critically low. Four treatment statuses of type- and energy-based ESWT were identified, including potential dominant efficacy (plantar fasciitis, erectile dysfunction, lateral epicondylitis, knee osteoarthritis, frozen shoulder, cerebral palsy spasticity, post-stroke lower limb spasticity; GRADE moderate), potential positive efficacy (chronic prostatitis/chronic pelvic pain syndrome, myofascial pain syndrome, patellar tendinopathy, achilles tendinopathy, stenosing tenosynovitis, frozen shoulder, rotator cuff tear, cerebral palsy spasticity, post-stroke upper limb spasticity, cervical spondylotic radiculopathy; GRADE low or very low), potential similar efficacy (osteonecrosis of the femoral head, plantar heel pain, patellar tendinopathy; GRADE low or very low), and potential adverse efficacy (patellar tendinopathy; GRADE very low). Along with courses of ESWT treatment, pain, flushing, and swelling were the most prevalent side effects and serious adverse reactions were limited.Conclusion Variable type- and energy-based ESWT is probably effective and safe in clinical practice. Due to lack of available data and high certainty in current evidence, future research should prioritize large-scale and well-designed studies.Registration PROSPERO number CRD42023477234Competing Interest StatementThe authors have declared no competing interest.Clinical TrialPROSPERO CRD42023477234Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023477234 Funding StatementThis work was supported by the National Natural Science Foundation of China (Grant number 82205245); the Natural Science Foundation of Guangdong, China (Grant number 2023A1515011143); Science and Technology Program of Guangzhou, China (Grant number 2023A04J0421); Teaching quality and teaching reform project of Southern Medical University in 2022(〔2022〕22); National College Student Innovation and Entrepreneurship Training Program (Grant number 202212121048 and 202312121264) in the collection, analysis and interpretation of data from X.Y.Zheng; the National Natural Science Foundation of China (Grant number 81873375 and 82174479) in the collection, analysis and interpretation of data from C.Z.Tang.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Databases: Epistemonikos database, Web of Science, Scopus database, Chinese National Knowledge Infrastructure, WANFANG Database, Chinese Scientific Journal Database, Chinese Biomedical Literature Database, PROSPERO, OpenGrey, Database of International Science Citation, Science Citation Index, and Google ScholarI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data in this study are collected from published articles; Materials are available in an online repository (Mendeley Data, v1; 2024. https://doi.org/10.17632/8jcbx3hzrv.1); Detailed datasets will be available upon reasonable request by emailing X.Y.Zheng. https://doi.org/10.17632/8jcbx3hzrv.1